MAY 27, 2021 7:00 AM PDT

Breakthrough Diagnostic Detects TB Infections in Infants Sooner

WRITTEN BY: Tara Fernandez

There are nearly a million cases of tuberculosis (TB) every year, and over 80 percent of childhood deaths from TB occur in those under 5 years old. A new diagnostic technology could help reduce the death toll from childhood TB. The test, created by researchers at Tulane University, looks for a protein called CFP-10 that is produced by Mycobacterium tuberculosis, the bacteria that causes TB infections. The assay can be performed on a small blood sample.

“This is a breakthrough for infants with tuberculosis because we don’t have this kind of screening technology to catch early infections among those youngest groups who are most likely to be undiagnosed,” said Tony Hu, lead author of the study published in BMC Medicine. “I hope this method can be pushed forward quickly to reach these children as early as possible.”

Current TB tests (mycobacterial culture and molecular diagnostic assays) rely on respiratory samples that are particularly difficult to obtain in infants and small children. Even if they are successfully obtained, samples from infected children contain significantly fewer bacteria than those from adults, meaning they are prone to receiving false-negative results.

CFP-10 is present in minute amounts in the circulation, but the assay developed by Hu and colleagues uses antibodies against the protein to separate it from the abundance of other proteins present in the blood. Mass spectrometry, a highly sensitive analytical technique that measures the mass of different molecules within a sample, is then used to accurately detect the presence of CFP-10.

In the study, Hu and colleagues used the new assay to screen samples from over 280 HIV-infected and 235 healthy children. The new test matched results from the current gold standard with 100% accuracy and additionally, detected 83.7 percent of TB cases that previously received false-negative results with standard tests.

On a positive note, the test alerted to the presence of TB in 77 percent of blood samples collected around 5 months before the children were diagnosed using other techniques. In some cases, the tests were able to pick up CFP-10 as early as a year before an official diagnosis.

As the next steps, Hu and colleagues are working towards a cost-effective, portable device that can perform the assay outside of a laboratory setting.

 

 

Source: Tulane University, BMC Medicine.


 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
JAN 19, 2021
Cardiology
Looking to the Immune System for Help Diagnosing Carotid Stenosis
JAN 19, 2021
Looking to the Immune System for Help Diagnosing Carotid Stenosis
Everyone has seen a commercial about how bad fats can build up into a plaque into a blood vessel. This is called atheros ...
FEB 23, 2021
Clinical & Molecular DX
Dogs Versus AI-Powered Diagnostic Devices-Who Won?
FEB 23, 2021
Dogs Versus AI-Powered Diagnostic Devices-Who Won?
We’ve heard of dogs sniffing out cancer—an unsurprising skill given that they have over 200 million scent re ...
MAR 18, 2021
Clinical & Molecular DX
"Hey Alexa, Are My Heart Rhythms Normal?"
MAR 18, 2021
"Hey Alexa, Are My Heart Rhythms Normal?"
Smart speakers—devices such as Amazon’s Echo and the Google Home—lend a helping hand around the house, ...
MAR 25, 2021
Cardiology
Improved Triage Method to Get STEMI Patients from Door to Treatment
MAR 25, 2021
Improved Triage Method to Get STEMI Patients from Door to Treatment
A heart attack is an incredibly sudden and dangerous cardiac event that requires quick action for a successful recovery. ...
APR 05, 2021
Clinical & Molecular DX
COVID Variants Can't Hide From CRISPR Diagnostic
APR 05, 2021
COVID Variants Can't Hide From CRISPR Diagnostic
New variants of the coronaviruses have emerged over the course of the pandemic through the natural evolutionary process ...
JUN 04, 2021
Clinical & Molecular DX
Tiny Bone Marrow Models Help Tailor Treatments for Platelet Disorder Patients
JUN 04, 2021
Tiny Bone Marrow Models Help Tailor Treatments for Platelet Disorder Patients
  Scientists have developed miniaturized 3-dimensional bone marrow models that could help physicians to predict whi ...
Loading Comments...